Verano Holdings (VRNO) Net Cash Flow Growth (3y) (2024 - 2026)
Verano Holdings (VRNO) Net Cash Flow Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | -28.90% |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | -5.41% |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 19.55% |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | 95.24% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -106.21% |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | 4.40% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 17.73% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Verano Holdings | 439.55 Mn | 354.35 Mn | 99.70 Mn | 14.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.46% |
| Mar 31, 2026 | -41.72% |
| Dec 31, 2025 | -77.00% |
| Sep 30, 2025 | 41.79% |
| Jun 30, 2025 | 30.59% |
| Mar 31, 2025 | -27.82% |
| Dec 31, 2024 | -18.53% |
| Sep 30, 2024 | 11.14% |